A bipartisan team of U.S. lawmakers has reintroduced the ALS Better Care Act, aimed at improving access to quality medical ...

Half of the planned 200 ALS patients have joined Medicinova’s expanded access program evaluating the experimental drug MN-166 ...

The ALS Network honors Jone López-Erauskin, PhD, UC San Diego, as the first recipient of the Fred Fisher Excellence in Research Award. Dr. López-Erauskin is recognized for outstanding scientific rigor ...

Former NFL player and renowned ALS advocate Steve Gleason, founder of Answer ALS and Team Gleason, is Participant #1, providing his sample collected at home to initiate the study. He will be joined by ...

KwaZulu-Natal MEC Siboniso Duma stands by claims against ALS Paramedics over crash response as legal threats escalate ...

While there is no cure for ALS, there have been about 65 rare cases where patients regain all, or nearly all, of their lost ...

When two hockey teams hit the ice Monday night, Feb. 2, the most important thing wasn’t winning or losing. The Mars Hockey ...

Ireland doesn’t exist. Bay leaves do absolutely nothing for your food. Lint rollers leave your clothes slightly sticky on ...

The Ice Bucket Challenge raised millions of dollars for research into treatments for ALS, or Lou Gehrig's disease. Where did ...

The ASX Healthcare sector felt the broader market’s chills for the week ending February 6, 2026, falling as tech and ... Read ...

“PathMaker Neurosystems is honored to have Prof. Donoghue as a member of its Board of Directors,” said Nader Yaghoubi, M.D., Ph.D., Co-Founder and Chief Executive Officer of PathMaker Neurosystems.

Detailed price information for Eledon Pharmaceuticals Inc (ELDN-Q) from The Globe and Mail including charting and trades.